Skip to menu Skip to content Skip to footer
Mr Mark Chatfield
Mr

Mark Chatfield

Email: 
Phone: 
+61 7 334 65042

Overview

Background

A/Prof Mark D. Chatfield is a highly experienced statistician and clinical trialist working at the UQ Clinical Trials Centre.

In collaboration with health and medical researchers, he has published >200 times in academic journals. He has been an investigator on 28 NHMRC/MRFF funded (>$56M) studies (mostly clinical trials). He has co-supervised 5 PhD students to completion, and is currently an advisor to 4 PhD students. He has over 20 years of experience as a biostatistician in Australia (Brisbane | Darwin | Sydney) and the UK (Cambridge, 2002-2009).

He plays an active role in the Australian Clinical Trials Alliance Statistics in Trials Interest Group.

Stata users around the world enjoy using his table1_mc command.

He is an Honorary Fellow (Associate Professor) with Menzies School of Health Research.

Availability

Mr Mark Chatfield is:
Available for supervision

Qualifications

  • Bachelor of Arts, University of Oxford
  • Masters (Coursework), University of Southampton
  • Masters (Coursework), University of Oxford

Research interests

  • Randomised Controlled Trials (RCTs)

    Mark has been involved with a plethora of trials of various designs in a broad range of fields. He makes considered, significant contributions to funding applications, trial design, analysis, presentation and interpretation. To date, he has published on 39 randomised trials (protocol and/or results paper). He is involved with methodological research into cluster randomised trials as well as sample size calculations and the anticipated width of 95% confidence intervals.

  • Ready interpretation of log-scale ouput

    Ready interpretation of log-scale ouput such as SD(ln Y), Bias(ln estimator). Symmetric percentage differences such as 100(A – B)/0.5(A + B)% or 100(lnA – lnB)%, Bland-Altman plots, and the summarising, modelling and plotting of lognormal data.

  • Meta analysis

    Mark has been involved with a variety of meta-analyses. He has found a novel way to interpret the heterogeneity parameter, tau, in random-effects meta-analysis of various ratios (e.g. odds ratio, ratio of means etc). He advocates for the reporting of tau (or exp(tau) for ratio measures) rather than tau^2 as it makes appreciating heterogeneity easier.

Works

Search Professor Mark Chatfield’s works on UQ eSpace

266 works between 2004 and 2025

221 - 240 of 266 works

2013

Conference Publication

The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC)

Mahon, Kate, Chatfield, Mark, Breit, Samuel, Brown, David, Molloy, Mark, Marx, Gavin, Pavlakis, Nick, Boyer, Michael, Stockler, Martin and Horvath, Lisa (2013). The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC). HOBOKEN: WILEY-BLACKWELL.

The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC)

2013

Journal Article

Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer

Grimison, Peter, Houghton, Baerin, Chatfield, Mark, Toner, Guy C., Davis, Ian D., Martin, Jarad, Hovey, Elizabeth and Stockler, Martin R. (2013). Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer. BJU International, 112 (2), E35-E43. doi: 10.1111/bju.12221

Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer

2013

Journal Article

Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer

Spina, R., Chu, S. Y. Y., Chatfield, M., Chen, J., Tin, M. M. and Boyer, M. (2013). Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer. Internal Medicine Journal, 43 (7), 790-797. doi: 10.1111/imj.12138

Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer

2013

Journal Article

Factors delaying chemotherapy for breast cancer in four urban and rural oncology units

Fox, Peter N., Chatfield, Mark D., Beith, Jane M., Allison, Stuart, Della-Fiorentina, Stephen, Fisher, Dean, Turley, Kim and Grimison, Peter S. (2013). Factors delaying chemotherapy for breast cancer in four urban and rural oncology units. ANZ Journal of Surgery, 83 (7-8), 533-538. doi: 10.1111/j.1445-2197.2012.06254.x

Factors delaying chemotherapy for breast cancer in four urban and rural oncology units

2013

Journal Article

Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma

Hong, Angela M., Martin, Andrew, Chatfield, Mark, Jones, Deanna, Zhang, Mei, Armstrong, Bruce, Lee, C. Soon, Harnett, Gerald, Milross, Christopher, Clark, Jonathan, Elliott, Michael, Smee, Robert, Corry, June, Liu, Chen, Porceddu, Sandro, Rees, Guy and Rose, Barbara (2013). Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. International Journal of Cancer, 132 (12), 2748-2754. doi: 10.1002/ijc.27956

Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma

2013

Journal Article

Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia

Bowen, Asha C., Tong, Steven Y. C., Chatfield, Mark D., Andrews, Ross M. and Carapetis, Jonathan R. (2013). Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 107 (6), 384-389. doi: 10.1093/trstmh/trt032

Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia

2013

Journal Article

Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy

Olver, I. N., Grimison, P., Chatfield, M., Stockler, M. R., Toner, G. C., Gebski, V., Harrup, R., Underhill, C., Kichenadasse, G., Singhal, N., Davis, I. D., Boland, A., McDonald, A. and Thomson, D. (2013). Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy. Supportive Care in Cancer, 21 (6), 1561-1568. doi: 10.1007/s00520-012-1696-0

Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy

2013

Conference Publication

The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC)

Horvath, Lisa, Chatfield, Mark D., Lee-Ng, Michelle, Lin, Hui-Ming, Castillo, Lesley, Breit, Samuel N., Brown, David A., Molloy, Mark P., Marx, Gavin M., Pavlakis, Nick, Boyer, Michael J., Stockier, Martin R., Wykes, Richard, Henshall, Susan M. and Mahon, Kate Lynette (2013). The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC). 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2013. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC)

2013

Journal Article

Health-related quality of life and inflammatory markers in malignant pleural mesothelioma

Kao, Steven C., Vardy, Janette, Harvie, Rozelle, Chatfield, Mark, van Zandwijk, Nico, Clarke, Stephen and Pavlakis, Nick (2013). Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer, 21 (3), 697-705. doi: 10.1007/s00520-012-1569-6

Health-related quality of life and inflammatory markers in malignant pleural mesothelioma

2013

Journal Article

Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease

Powell, Jonathan J., Cook, William B., Chatfield, Mark, Hutchinson, Carol, Pereira, Dora I. A. and Lomer, Miranda C. E. (2013). Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease. Nutrition & Metabolism, 10 (1) 18. doi: 10.1186/1743-7075-10-18

Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease

2013

Journal Article

Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease

Powell, Jonathan J., Cook, William B., Hutchinson, Carol, Tolkien, Zoe, Chatfield, Mark, Pereira, Dora I. A. and Lomer, Miranda C. E. (2013). Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Nutrition & Metabolism, 10 (1) 9. doi: 10.1186/1743-7075-10-9

Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease

2013

Conference Publication

A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial

Mccallum, G., Morris, P. S., Chatfield, M. D., Maclennan, C., White, A., Versteegh, L., Wilson, C., Jacobsen, N. and Chang, A. B. (2013). A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT, Australia, 22-27 March 2013. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/resp.12046

A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial

2013

Journal Article

Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer

Hong, A. M., Martin, A., Armstrong, B. K., Lee, C. S., Jones, D., Chatfield, M. D., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Smee, R., Corry, J., Liu, C., Porceddu, S., Vaska, K., Veness, M., Morgan, G., Fogarty, G., Veivers, D., Rees, G. and Rose, B. (2013). Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology, 24 (1) mds205, 215-219. doi: 10.1093/annonc/mds205

Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer

2013

Journal Article

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales dust diseases board

Kao, Steven C., Vardy, Janette, Chatfield, Mark, Corte, Peter, Pavlakis, Nick, Clarke, Christopher, van Zandwijk, Nico and Clarke, Stephen (2013). Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales dust diseases board. Clinical Lung Cancer, 14 (1), 70-77. doi: 10.1016/j.cllc.2012.03.011

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales dust diseases board

2012

Journal Article

Electroacupuncture for nausea, vomiting, and myelosuppression in women receiving adjuvant chemotherapy for early breast cancer: a randomized controlled pilot trial

Beith, Jane M., Oh, Byeongsang, Chatfield, Mark D., Davis, Esther and Venkateswaran, Ramya (2012). Electroacupuncture for nausea, vomiting, and myelosuppression in women receiving adjuvant chemotherapy for early breast cancer: a randomized controlled pilot trial. Medical Acupuncture, 24 (4), 241-248. doi: 10.1089/acu.2012.0876

Electroacupuncture for nausea, vomiting, and myelosuppression in women receiving adjuvant chemotherapy for early breast cancer: a randomized controlled pilot trial

2012

Journal Article

Dietary iron is associated with memory in midlife: longitudinal cohort study

Rickard, Anna P., Chatfield, Mark D., Powell, Jonathan J., Stephen, Alison M. and Richards, Marcus (2012). Dietary iron is associated with memory in midlife: longitudinal cohort study. Journal of Pharmacy and Nutrition Sciences, 2 (1), 57-62. doi: 10.6000/1927-5951.2012.02.01.8

Dietary iron is associated with memory in midlife: longitudinal cohort study

2012

Journal Article

Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma

Sundaresan, P., Hruby, G., Hamilton, A., Hong, A., Boyer, M., Chatfield, M. and Thompson, J. F. (2012). Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma. Clinical Oncology, 24 (9), E131-E136. doi: 10.1016/j.clon.2012.04.007

Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma

2012

Journal Article

Antibiotics for bronchiectasis exacerbations in children: Rationale and study protocol for a randomised placebo-controlled trial

Chang, Anne B., Grimwood, Keith, Robertson, Colin F., Wilson, Andrew C., van Asperen, Peter P., O'Grady, Kerry-Ann F., Sloots, Theo P., Torzillo, Paul J., Bailey, Emily J., Mccallum, Gabrielle B., Masters, Ian B., Byrnes, Catherine .A, Buntain, Helen M., Morris, Peter S., Mackay, Ian M. and Chatfield, Mark D. (2012). Antibiotics for bronchiectasis exacerbations in children: Rationale and study protocol for a randomised placebo-controlled trial. Trials, 13 (156) 156, 156-1-156-9. doi: 10.1186/1745-6215-13-156

Antibiotics for bronchiectasis exacerbations in children: Rationale and study protocol for a randomised placebo-controlled trial

2012

Journal Article

High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy

Savdie, Richard, Horvath, Lisa G., Benito, Ruth Pe, Rasiah, Krishan K., Haynes, Anne-Maree, Chatfield, Mark, Stricker, Phillip D., Turner, Jennifer J., Delprado, Warwick, Henshall, Susan M., Sutherland, Robert L. and Kench, James G. (2012). High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU International, 109 (12), 1794-1800. doi: 10.1111/j.1464-410X.2011.10572.x

High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy

2012

Conference Publication

Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC)

Sjoquist, Katrin Marie, Lee, Chee, Lord, Sally, Chatfield, Mark D., Friedlander, Michael, Simes, John and Marschner, Ian (2012). Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC). 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.

Progression-free survival (PFS) as a surrogate end point for overall survival (OS) in first-line treatment of advanced epithelial ovarian cancer (EOC)

Funding

Current funding

  • 2025 - 2028
    Improving Food Allergy Outcomes in Adolescents
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2024 - 2027
    Co-creating virtual environments with consumers to enhance self-awareness and preparedness for home after brain injury
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2023 - 2028
    The clinical and cost-effectiveness of lumbar fusion surgery for patients with persistent, severe low back pain: FusiOn veRsus bEst coNServative Care (the FORENSIC trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2023 - 2027
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2023 - 2026
    Pharmacogenomics for better treatment of fungal infections in cancer
    MRFF Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
    Open grant
  • 2022 - 2028
    ACTIVE KNEECAPs! tArgeted effeCTIVE treatments for adolescent KNEECAP pain
    NHMRC MRFF EPCDR - Chronic Musculoskeletal Conditions in Children and Adolescents
    Open grant
  • 2022 - 2027
    Optimising Care: Phase III Trial in women with metastatic breast cancer to improve quality of life via exercise and diet (Stream 6)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2026
    Technology Assisted and Remotely Delivered Anxiety Psychotherapy Intervention for People living with Dementia and Their Care Partners (Tech-CBT)
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2019 - 2025
    Preventing recurrent respiratory-related hospitalisations in young Indigenous children through regular azithromycin: a multi-centre.... (NHMRC Project Grant led by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant

Past funding

  • 2019 - 2024
    Improving outcomes of children and young adults with primary ciliary dyskinesia (PCD):... (MRFF RCRDUN administered by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant
  • 2019
    Cluster randomised trial of Staphylococcus aureus decolonisation to prevent surgical site infections
    HCF Research Foundation
    Open grant

Supervision

Availability

Mr Mark Chatfield is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Statistical advisor (but NOT primary supervisor)

    I am available to be a statistical advisor, but am not available to be a primary supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Mr Mark Chatfield's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au